← All trials
NCT04381936
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 19, 2020
- Primary completion
- Dec 31, 2020
- Completion date
- Jun 30, 2021
- First posted
- May 11, 2020
- Last posted
- May 11, 2020
- Enrollment
- 12000
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of OxfordLead sponsor
- University of OxfordOverall official - principal investigator
- National Institute for Health Research, United KingdomCollaborator
- Bill and Melinda Gates FoundationCollaborator
- Medical Research CouncilCollaborator
- Government of United KingdomCollaborator
- Wellcome TrustCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.